Semaglutide, with its 165-hour half-life, requires only a weekly injection
These injections help enhance the livers ability to metabolize fat, optimize hormone function, and improve overall energy levels

Table of Contents Introduction Objective of the study Product Definition Market Segmentation Study Variables Research Methodology Secondary Data Points Companies Interviewed Primary Data Points Break Down of Primary Interviews Executive Summary Market Dynamics Drivers Challenges Opportunity Assessment Recent Trends and Developments Policy and Regulatory Landscape Sweden Semaglutide Market Overview (2020-2032) Market Size, By Value (in USD Billions) Market Share, By Brand Ozempic Wegovy Rybelsus Market Share, By Distribution Channel Hospital Pharmacies Retail Pharmacies Online Pharmacies Market Share, By Competitors Competition Characteristics Revenue Shares Sweden Ozempic Semaglutide Market Overview, 2020-2032F By Value (USD Million) Sweden Wegovy Semaglutide Market Overview, 2020-2032F By Value (USD Million) Sweden Rybelsus Semaglutide Market Overview, 2020-2032F By Value (USD Million) Competitive Outlook (Company Profile - Partila List) Novo Nordisk A/S Company Overview Business Segments Strategic Alliances/Partnerships Recent Developments Eli Lilly and Company Company Overview Business Segments Strategic Alliances/Partnerships Recent Developments Sanofi S.A

Taking extra doses increases the risk of serious adverse events including severe gastrointestinal distress, pancreatitis, and unpredictable blood sugar changes
Oral semaglutide ($289/mo starting price) does not slow gastric emptying as aggressively as injections, so some patients experience less bloating